Daniel F Hayes Selected Research

Cyclophosphamide (Cytoxan)

12/2019	Validation of the DNA Damage Immune Response Signature in Patients With Triple-Negative Breast Cancer From the SWOG 9313c Trial.
1/2019	Germline Genetic Variants in GATA3 and Breast Cancer Treatment Outcomes in SWOG S8897 Trial and the Pathways Study.
1/2012	Phase II trial of simple oral therapy with capecitabine and cyclophosphamide in patients with metastatic breast cancer: SWOG S0430.
12/2011	Genetic predictors of taxane-induced neurotoxicity in a SWOG phase III intergroup adjuvant breast cancer treatment trial (S0221).
8/2011	p53 Expression in node-positive breast cancer patients: results from the Cancer and Leukemia Group B 9344 Trial (159905).
12/2010	Gene polymorphisms in cyclophosphamide metabolism pathway,treatment-related toxicity, and disease-free survival in SWOG 8897 clinical trial for breast cancer.
11/2010	Manganese superoxide dismutase polymorphism, treatment-related toxicity and disease-free survival in SWOG 8897 clinical trial for breast cancer.
1/2010	Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial.
8/2009	Outcome of patients with early-stage breast cancer treated with doxorubicin-based adjuvant chemotherapy as a function of HER2 and TOP2A status.
7/2009	Topoisomerase II{alpha} amplification does not predict benefit from dose-intense cyclophosphamide, doxorubicin, and fluorouracil therapy in HER2-amplified early breast cancer: results of CALGB 8541/150013.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel F Hayes Research Topics

Disease

187	Breast Neoplasms (Breast Cancer) 11/2022 - 02/2002
97	Neoplasms (Cancer) 10/2022 - 02/2002
17	Circulating Neoplastic Cells 01/2022 - 03/2005
11	Neoplasm Metastasis (Metastasis) 01/2018 - 08/2003
8	Pain (Aches) 10/2022 - 09/2008
7	Peripheral Nervous System Diseases (PNS Diseases) 01/2022 - 01/2018
7	Hot Flashes 11/2015 - 04/2002
6	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 02/2003
5	Leukemia 08/2011 - 02/2002
4	Triple Negative Breast Neoplasms 12/2019 - 12/2016
4	Disease Progression 12/2019 - 07/2006
3	Carcinoma (Carcinomatosis) 04/2021 - 05/2014
3	Cognitive Dysfunction 10/2020 - 09/2014
3	Pathologic Complete Response 10/2019 - 08/2005
3	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 07/2010 - 12/2008
3	Colorectal Neoplasms (Colorectal Cancer) 04/2009 - 11/2006
2	Osteonecrosis (Kienbock's Disease) 01/2022 - 01/2020
2	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2020 - 01/2020
2	Second Primary Neoplasms (Neoplasms, Second) 07/2018 - 01/2013
2	Cardiovascular Diseases (Cardiovascular Disease) 03/2016 - 02/2012
2	Syndrome (Syndromes) 01/2016 - 08/2014
2	Fatigue 09/2014 - 08/2014
2	Chronic Pain 05/2014 - 12/2011
2	Lung Neoplasms (Lung Cancer) 10/2013 - 11/2011
2	Colonic Neoplasms (Colon Cancer) 11/2011 - 11/2006
1	Bone Diseases (Bone Disease) 01/2022

Drug/Important Bio-Agent (IBA)

43	Hormones (Hormone)IBA 10/2022 - 02/2003
36	Estrogen ReceptorsIBA 11/2022 - 03/2003
29	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2004
23	Tumor Biomarkers (Tumor Markers)IBA 01/2021 - 03/2005
22	Tamoxifen FDA LinkGeneric 03/2022 - 02/2002
20	Aromatase InhibitorsIBA 10/2022 - 09/2006
19	Estrogens (Estrogen)FDA Link 03/2022 - 12/2008
18	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2003
16	exemestane (Aromasin)FDA Link 10/2022 - 09/2008
16	Letrozole (Femara)FDA LinkGeneric 10/2022 - 09/2008
16	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2019 - 02/2002
16	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2019 - 02/2002
14	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 01/2003
13	Progesterone Receptors (Progesterone Receptor)IBA 01/2020 - 12/2008
10	human ERBB2 proteinIBA 12/2021 - 01/2007
9	DNA (Deoxyribonucleic Acid)IBA 04/2021 - 04/2006
9	Pharmaceutical PreparationsIBA 10/2017 - 03/2003
9	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 09/2013 - 12/2003
7	ErbB Receptors (EGF Receptor)IBA 11/2022 - 10/2007
7	Fulvestrant (Faslodex)FDA Link 03/2022 - 08/2012
6	Biological ProductsIBA 10/2022 - 01/2010
6	Circulating Tumor DNAIBA 01/2022 - 10/2017
6	Anastrozole (Arimidex)FDA LinkGeneric 01/2022 - 03/2012
6	RNA (Ribonucleic Acid)IBA 04/2021 - 05/2002
6	AnthracyclinesIBA 01/2020 - 06/2002
6	ParaffinIBA 12/2019 - 08/2011
5	Formaldehyde (Formol)FDA Link 12/2019 - 08/2011
5	Fluorouracil (Carac)FDA LinkGeneric 01/2019 - 02/2002
4	taxaneIBA 10/2022 - 12/2011
4	Capecitabine (Xeloda)FDA Link 01/2012 - 07/2006
3	Estradiol (Delestrogen)FDA LinkGeneric 03/2022 - 05/2012
3	AZD9496IBA 03/2022 - 12/2018
3	Bevacizumab (Avastin)FDA Link 01/2022 - 12/2007
3	LigandsIBA 04/2020 - 12/2018
3	Trastuzumab (Herceptin)FDA Link 11/2017 - 12/2008
3	ametantrone (HAQ)IBA 07/2017 - 09/2008
3	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 11/2015 - 02/2003
3	Carcinoembryonic AntigenIBA 08/2015 - 11/2006
2	Everolimus FDA Link 01/2022 - 01/2013
2	Diphosphonates (Bisphosphonates)IBA 01/2022 - 01/2020
2	Zoledronic Acid (Zometa)FDA Link 01/2022 - 01/2020
2	Monoclonal AntibodiesIBA 01/2021 - 04/2009
2	B7-H1 AntigenIBA 01/2021 - 01/2018
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2018
2	Androgen Receptors (Androgen Receptor)IBA 01/2017 - 07/2003
2	Phosphotransferases (Kinase)IBA 12/2016 - 01/2016
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 04/2016 - 12/2008
2	Plasminogen Activators (Plasminogen Activator)IBA 04/2016 - 12/2008
2	LipidsIBA 03/2016 - 12/2012
2	Progesterone FDA LinkGeneric 01/2016 - 05/2015
2	Docetaxel (Taxotere)FDA Link 03/2013 - 07/2007
2	4-hydroxy-N-desmethyltamoxifenIBA 03/2012 - 07/2006
2	Serotonin (5 Hydroxytryptamine)IBA 12/2011 - 04/2002
2	AntibodiesIBA 08/2011 - 06/2009
2	EnzymesIBA 11/2010 - 01/2005
2	Prostate-Specific Antigen (Semenogelase)IBA 12/2008 - 02/2003
2	Cyclin EIBA 11/2007 - 12/2006
2	Thymidine PhosphorylaseIBA 07/2007 - 11/2006
2	Paroxetine (Paxil)FDA LinkGeneric 10/2005 - 12/2003
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2005 - 12/2003
1	Pamidronate (Aredia)FDA LinkGeneric 01/2022
1	thymidine kinase 1IBA 11/2021

Therapy/Procedure

94	Therapeutics 11/2022 - 04/2002
40	Drug Therapy (Chemotherapy) 12/2021 - 01/2003
23	Adjuvant Chemotherapy 01/2021 - 06/2002
7	Neoadjuvant Therapy 10/2019 - 04/2002
6	Radiotherapy 01/2020 - 04/2002
4	Precision Medicine 01/2022 - 01/2014
4	Lymph Node Excision (Lymph Node Dissection) 10/2007 - 04/2002
3	Aftercare (After-Treatment) 11/2017 - 12/2006
2	Time-to-Treatment 10/2022 - 01/2006
2	Mastectomy (Mammectomy) 05/2015 - 09/2009
2	Chemoprevention 02/2010 - 11/2004
2	Segmental Mastectomy (Lumpectomy) 09/2009 - 04/2002